NP

Nagma Perween

Active Director Director DIN 10269413
DIN 10269413 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Nagma Perween

Data last updated:

Nagma Perween is a Director at Tapsa Health Research Laboratory Private Limited (since 2023). Tapsa Health Research Laboratory Private Limited reported revenue of ₹2.4 Lakh (FY 2025).

DIN 10269413
Primary Designation Director
First Appointment 07 Aug 2023
Oldest Company Age 3 yrs
Largest company Tapsa Health Research Laboratory Private Limited · ₹2.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20232023₹2.4 Lakh (FY 2025)Active

Board colleagues of Nagma Perween

NameDINCompanyDesignation
Tarique Azam10269412Tapsa Health Research Laboratory Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tapsa Health Research Laboratory Private Limited
Premium access

Shareholding and investment profile for Nagma Perween

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagma Perween

Nagma Perween currently holds 1 directorship: Tapsa Health Research Laboratory Private Limited (Director, since 07 Aug 2023, revenue ₹2.4 Lakh (FY 2025)).

Nagma Perween was first appointed on 07 Aug 2023 as Director at Tapsa Health Research Laboratory Private Limited.

The current boards of Nagma Perween's companies include Tarique Azam (Tapsa Health Research Laboratory Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available